Int J Med Sci 2019; 16(2):203-211. doi:10.7150/ijms.29637 This issue Cite

Review

Current status of endovascular treatment for dural arteriovenous fistulae in the anterior cranial fossa: A systematic literature review

Kan Xu1*, Tiefeng Ji2*, Chao Li3, Jinlu Yu1✉

1. Department of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, China
2. Department of Radiology, The First Hospital of Jilin University, Changchun, 130021, China
3. Department of Neurology, The First Hospital of Jilin University, Changchun, 130021, China
*These authors contributed equally to this work.

Citation:
Xu K, Ji T, Li C, Yu J. Current status of endovascular treatment for dural arteriovenous fistulae in the anterior cranial fossa: A systematic literature review. Int J Med Sci 2019; 16(2):203-211. doi:10.7150/ijms.29637. https://www.medsci.org/v16p0203.htm
Other styles

File import instruction

Abstract

Anterior cranial fossa (ACF) dural arteriovenous fistulae (DAVFs) are rare, and a systematic review of the literature is lacking. Such a review is necessary, however, so a systematic PubMed search of related studies was performed. Twenty-four studies were identified, reporting on 48 patients, of whom 39 had definite age and sex information and 33 (84.6%, 33/39) were male. The afflicted patients were between 37 and 80 years old (mean 55.6). Among the 48 patients, 28 (58.3%, 28/48) primarily presented with intracranial hemorrhage, 47 (97.9%, 47/48) had feeding arteries from the anterior ethmoidal artery (AEA) of the ophthalmic artery (OA), and 40 (83.3%, 40/48) had bilateral feeding arteries. All of the cases had high-grade Cognard classifications (III-IV). Among the 48 patients, 43 (89.6%, 43/48) had drainage into the superior sagittal sinus (SSS). In addition, 36 (75%, 36/48) patients were treated via transarterial embolization (TAE). Of these patients, 28 (77.8%, 28/36) were managed via the AEA of the OA. Another 12 (25%, 12/48) patients were treated via transvenous embolization (TVE), 11 of whom (91.7%, 11/12) were treated with the trans-SSS approach. Complete angiographic cure was achieved in 44 (91.7%, 44/48) patients, with 4 (8.3%, 4/48) patients suffering from postprocedural complications. All 48 patients had clear descriptions of follow-up outcomes, with 45 (93.8%, 45/48) patients having a good outcome. Thus, when treating ACF DAVFs, endovascular treatment (EVT) can completely obliterate the fistula point and correct the venous shunting. EVT is therefore an effective treatment for ACF DAVF. Although many complications can occur, this approach achieves good outcomes in most cases.

Keywords: endovascular treatment, dural arteriovenous fistula, anterior cranial fossa, systematic review


Citation styles

APA
Xu, K., Ji, T., Li, C., Yu, J. (2019). Current status of endovascular treatment for dural arteriovenous fistulae in the anterior cranial fossa: A systematic literature review. International Journal of Medical Sciences, 16(2), 203-211. https://doi.org/10.7150/ijms.29637.

ACS
Xu, K.; Ji, T.; Li, C.; Yu, J. Current status of endovascular treatment for dural arteriovenous fistulae in the anterior cranial fossa: A systematic literature review. Int. J. Med. Sci. 2019, 16 (2), 203-211. DOI: 10.7150/ijms.29637.

NLM
Xu K, Ji T, Li C, Yu J. Current status of endovascular treatment for dural arteriovenous fistulae in the anterior cranial fossa: A systematic literature review. Int J Med Sci 2019; 16(2):203-211. doi:10.7150/ijms.29637. https://www.medsci.org/v16p0203.htm

CSE
Xu K, Ji T, Li C, Yu J. 2019. Current status of endovascular treatment for dural arteriovenous fistulae in the anterior cranial fossa: A systematic literature review. Int J Med Sci. 16(2):203-211.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image